Defense Secretary Pete Hegseth announced a new testosterone-deficiency screening program for service members, but endocrinologist and former military doctor Dr. Karl Nadolsky says the science doesn’t support universal testing in people without symptoms. In this episode, we break down who should be evaluated, why obesity/sleep apnea and certain injuries or medications can lower testosterone, and what risks come with unnecessary testosterone replacement therapy (including infertility).

00:00 intro
00:01:00 Meet Dr. Karl Nadolsky (endocrinologist, former military physician)
00:02:02 Full clip: Pete Hegseth explains annual testing for 30+; optional under 30
00:04:31 What testosterone does/doesn’t do for performance; who truly benefits from TRT
00:05:30 How common is “true” hypogonadism vs functional low T (obesity/sleep apnea/diabetes)
00:06:48 Why widespread screening isn’t recommended; lack of evidence for better outcomes
00:08:44 Medication/injury causes: opioids, TBI, blast/testicular trauma; why targeted screening fits
00:11:59 Main risks: false positives, wrong timing/conditions for labs, unnecessary anxiety/cost
00:13:38 Proper workup: treat root causes first; don’t miss pituitary disease or sleep apnea
00:14:06 TRT tradeoffs: fertility suppression, potential long-term dependence; steroid/male-clinic pitfalls
00:16:16 Women and testosterone: testing mostly for high levels; limited menopause libido use
00:19:29 Military endocrinology + why expert input/task force matters for policy
00:22:15 Practical alternative: checkbox-based risk triggers and symptom screening at annual physicals
00:23:34 Closing: keep politics out; follow data and build evidence-based protocols

Host Kari Beal interviews Dr. George Ibrahim about the surge in peptide use for injury recovery, energy, weight loss, and more, plus why many peptides aren’t FDA-approved and have limited human data. They break down common peptides (BPC-157, TB-500, CJC-1295/ipamorelin), discuss safety and cancer/angiogenesis concerns, and explain why buying “research peptides” online can be risky.

00:00 intro
00:01 BPC-157 & TB-500 explained (repair/cleanup crews); angiogenesis + cancer concern setup.
00:03 What a peptide is; how structure drives function (key/receptor).
00:05 Evidence overview (animal vs limited human); why combine BPC-157 + TB-500.
00:07 Safety in practice: “peptide flush” and minor reactions.
00:08 Cancer-risk discussion; screening for cancer history.
00:10 Quality control: pharmacy “human-use” vs online “research” peptides; contamination/dosing risks.
00:12 How to tell: if you can buy it yourself online, it’s not human-use.
00:14 “Best” peptide pick: CJC-1295 + ipamorelin; growth-hormone support + realistic timeline.
00:17 Cost estimates; prioritizing hormones, then GH support.
00:18 Why few human trials (patents/funding).
00:20 FDA/compounding outlook; regulation and safety hopes.
00:22 Social media hype; questions to ask a doctor; special cautions (GLP-1s, tanning peptides).
00:24 More peptide uses (GHK-Cu for brain + hair/skin/nails); closing + correction (“endotoxins”).

A new FDA-approved treatment for Hunter syndrome (MPS II) is giving families hope, but it’s not a cure. We explore how close researchers may be to a cure, including promising gene therapy clinical trials, and what experts say still needs long-term study.

00:00 intro
00:45 How this story began: a mom reaches out about newly approved Avlayah.
01:03 Why it matters: therapy designed to cross the blood-brain barrier.
01:20 The emotional center: two moms bond while navigating the same diagnosis.
02:23 Hunter syndrome (MPS II) explained: missing enzyme, sugar buildup, organ/brain damage.
03:40 How the “next-gen” enzyme replacement works using an enzyme transport vehicle.
04:16 Early impact: reported behavioral/physical improvements and infusion-center support.
05:36 “Not a cure” → what a cure could look like; intro to gene therapy.
06:23 London trial spotlight: one-time ex vivo gene therapy; early (anecdotal) improvements. https://www.gosh.nhs.uk/news/gosh-manufactures-new-gene-therapy-for-rare-condition/
08:01 U.S. clinical trial in New Jersey: timelines and what’s still unknown. https://clinicaltrials.gov/study/NCT07236606
08:48 Physician Assistant Laura Buch: long-term durability, dosing questions, and rare-disease trial limits.
10:03 Advocacy + how to find trials on ClinicalTrials.gov; closing thoughts.
https://clinicaltrials.gov/study/NCT03566043

The federal government is fast-tracking some psychedelic-based medicines for research and development. Emergency physician Dr. Jonathan Leak explains how these therapies may work in the brain and if they’re safe.

00:00 — Fire captain recounts suicidal crisis; psilocybin changes his outlook and family life
00:36 — Intro: what psychedelics might do (neurotransmitters/neuroplasticity) and the safety question
00:54 — Why now: executive order to speed development; focus on treatment-resistant depression, PTSD, addiction
01:23 — Arizona psilocybin trial for first responders; content warning for sensitive topics
02:05 — Mark Herman’s story: chronic trauma, “fight or flight,” and seeking relief
03:01 — Research barriers from past criminalization; trial details and demand/waitlist
04:22 — Career risks/stigma for officers; underground use; dosing and safety concerns
05:01 — Black market concerns; funding push; hopes for right-to-try and guardrails as access expands
07:20 — Interview begins: Dr. Leak’s credentials; ketamine currently used in psychedelic therapy
08:15 — What drugs are discussed: psilocybin, ibogaine, methylone/MDMA
09:00 — Evidence/history; why these may help PTSD, depression, addiction
10:53 — How they may work: receptors + neuroplasticity + psychedelic experience; importance of therapy integration
12:36 — Brain connectivity shifts; new pathways; how psilocybin is dosed and how long sessions last
15:01 — Patents/formulations; molecule tweaks vs process patents
16:02 — MDMA/methylone differences; trauma processing and study outcomes; need for certified care
18:08 — Clinic model questions; side effects, monitoring, and scaling sessions safely

Musician Carnie Wilson is raising awareness about tardive dyskinesia (TD), an uncontrolled movement disorder that often goes undiagnosed. She shares why she’s advocating for screening, how stigma can keep people silent, and where listeners can find support and resources. 

00:00 – intro
00:01:05 – What TD is: common symptoms (face/lips, chewing-like movements, eye twitch).
00:01:29 – Main cause: dopamine receptor–blocking meds (often antipsychotics); risk factors + generations of meds.
00:02:21 – Why TD is missed: many cases undiagnosed; importance of recognizing symptoms.
00:02:42 – Carnie on speaking up, getting screened, and how diagnosis can change lives.
00:04:53 – “Connecting with Carnie” campaign + where to find resources (connectingwithcarney.com).
00:05:24 – Bell’s palsy story as a way to relate to visible conditions and shame/stares.
00:07:10 – What helps diagnosis: noticing changes, telling your healthcare provider, rejecting shame.
00:09:33 – How TD impacts daily life (driving, sleep, leaving home) + real patient stories.
00:10:17 – Carnie on depression/addiction, stigma, and checking in on mental health.
00:14:23 – Medication/research question; Carnie points listeners back to medical resources.
00:16:18 – Why this cause matters to her: family experience with mental illness + compassion.
00:19:10 – Specific symptoms to watch for + encouragement to seek help.
00:20:30 – Final call to visit the campaign site; thanks and outro. 

USC School of Medicine Greenville experts break down lifestyle medicine and the evidence behind its “six pillars.” They discuss how food, exercise, sleep, stress management, social connection, and avoiding risky substances can improve chronic disease outcomes—and even support brain health in depression, Alzheimer’s risk, and more.

00:00 Intro
00:47 Welcome + live event at USC School of Medicine Greenville
02:10 Guest intros: Dean/primary care, neuroscientist, lifestyle program director
03:00 Why lifestyle medicine matters in med school + patient care
07:27 Real-life examples: hypertension, sodium, “food as medicine” (beets/flax)
09:13 Exercise & depression: blood flow, muscle-brain signaling, BDNF
12:35 Brain health + dementia risk: six pillars may slow cognitive decline
14:05 Parkinson’s study: tandem cycling benefits patients + caregivers
14:49 Curriculum: 109+ hours integrated across 4 years
15:51 Gut-brain connection: microbiome, fiber, ultra-processed foods
19:03 Social connection: loneliness, group care, “social capital”
22:21 Lifestyle vs functional medicine; the six pillars defined
23:40 Supplements + misinformation; magnesium; third-party testing (USP)
26:02 How to vet health info online (“too good to be true”)
29:02 Audience Q&A: antidepressants timeline; exercise outdoors
31:06 Motivation strategies: small goals, remove barriers, prioritize sleep
32:27 Organic vs frozen produce: cost-effective options + washing
35:07 Exercise guidelines by age + strength training + bone health
38:05 Cooking skills: culinary medicine + mobile teaching kitchen

After a seizure led to the discovery of a brain mass, FOX Carolina news anchor Tori Carmen shares the whirlwind from surgery to an unexpected malignant diagnosis and how recovery has challenged her physically and emotionally. One year later, she explains the tools that helped her cope (therapy, nature, faith, community) and the lifestyle shifts she’s made to support long-term health.

00:00 Intro
02:23 Seizure night, ER trip, CT scan, loss of right-side function.
04:12 Tumor location/size; next steps; wedding plans change; surgery set at Northwestern.
05:28 Meningioma explained; surgery + early recovery; can’t drive; pathology surprise.
07:23 Grade 3 malignant diagnosis; neuro-onc/radiology consults; choosing gamma knife.
10:18 Radiation day + side effects; returning to work; hair loss grief/identity shift.
13:18 Ongoing MRIs; seizure meds; rebuilding strength; stress on body/mind.
14:27 Coping tools: therapy, walks, nature, prayer, dogs; purpose + advocacy.
16:17 “Be kind” message; invisible battles; connection and support systems.
22:28 New normal: rest, boundaries, saying no; redefining productivity.
26:07 Staying active: weighted-vest walks, Pilates, shorter workouts; heat sensitivity.
28:05 Nutrition/toxin reduction: local/organic, baking soda wash, fewer plastics/chemicals.
28:50 Giving up alcohol; mocktails; better sleep/skin/gut.
34:04 Western + functional medicine balance; tests, supplements, inflammation focus.
38:20 Birth control + meningioma discussion; hormone caution + research.
41:18 Migraine scare + ER fear; stress triggers; clear MRI.
44:27 Fear of recurrence; faith + focusing on the present; advice to others.

X Ambassadors keyboardist and Grammy-winning musician Casey Harris shares what it’s like living with Leber’s congenital amaurosis and how learning music by ear shaped his career. He also explains why he partnered with Vision Through Music to connect blind and visually impaired kids with trained music teachers and why more educators are urgently needed.

Vision Through Music: https://childrenseyefoundation.org/what-we-do/vision-through-music/
Sign up for The Wellness Files event: https://www.foxcarolina.com/2026/05/04/join-our-live-event-learn-about-lifestyle-medicine

00:00 Intro
01:02 Host welcome; Wellness Files live event + where to watch featured story
01:58 Casey’s role with X Ambassadors + Vision Through Music partnership overview
02:30 Quick tangent: screens/eye health takeaway
03:24 Casey’s upbringing in Ithaca, NY; music-filled home and early lessons
05:30 Mentors/teachers + learning to play by ear; jamming as “wordless” communication
08:24 Early recording/producing at home; building bands with friends/brother
09:49 What his vision is like; adapting to dark venues and fully blind workflows
11:46 Ear training/transcription vs. sheet music; how it shaped his musicianship
13:21 Diagnosis: Leber’s congenital amaurosis + Senior-Løken syndrome; importance of aides/teachers
14:57 Vision Through Music mission: matching/training teachers for blind/low-vision students
18:20 More blind musicians he’s met; piano tuning program experience
20:00 Call to action: need teachers (incl. Carolinas); virtual training/resources
22:19 Why music is empowering for disability community; confidence and purpose
24:35 Wrap-up + links/resources; where to follow the podcast/host

A groundbreaking randomized trial in Kinston, North Carolina is testing fluoridated vs. non-fluoridated water in young children to produce the most rigorous evidence yet on fluoride’s real-world benefits today.  

00:00 Intro
01:01 Quick history setup: how fluoridation began and why it became widespread.
01:20 Early clues: mottled teeth but fewer cavities; investigators suspect water.
01:40 Fluoride identified in water; dental fluorosis linked to high levels.
02:13 Grand Rapids becomes first to fluoridate; endorsements follow.
02:38 UNC dentistry expertise and an under-the-radar, ongoing study.
03:33 Kinston removes fluoride—setting up the WaterBeST Treatment Study.
03:52 Observational vs. randomized research and why randomization matters.
04:31 Study design: 200 families, blinded fluoridated vs. non-fluoridated bottled water.
04:53 Measuring total fluoride exposure via toenail clippings.
05:21 Potential expanded outcomes (e.g., IQ) if funded; results expected 2029.
06:34 How fluoride’s cavity-prevention benefit has changed; biggest gains for low-income families.
07:20 Promo: live event on lifestyle medicine (May 21, 2026) + wrap-up. 

Cities across the U.S. are battling over a question that hits close to home: what’s really in your tap water and what could it mean for kids? In Part 1, host Kari Beal goes on the road to investigate fluoride fears concerns, breaking down the latest science on thyroid markers, IQ findings, and why dosage matters, with a leading researcher explaining what we know (and what we still don’t).

RSVP for The Wellness files live here: https://app.smartsheet.com/b/form/019d96a1f3f77b339a49f323e7064032

Studies:
Thyroid: https://pmc.ncbi.nlm.nih.gov/articles/PMC11003687/
IQ: https://ntp.niehs.nih.gov/research/assessments/noncancer/completed/fluoride
IQ: https://twin-cities.umn.edu/news-events/fluoride-drinking-water-does-not-harm-childrens-iq

00:00 Tap water question; why fluoride is controversial
00:00:37 Welcome + episode setup (broadcast story format)
00:01:21 Brevard, NC intro; notable choice: no fluoride in tap water
00:02:03 Parent/council member Maurice Jones shares child health concerns
00:02:26 Hypothyroidism explained; why fluoride studies worry some families
00:02:58 Expert interview: USC chemist Susan Richardson explains fluoride basics
00:03:24 Benefits at low levels; risks of too much (fluorosis)
00:03:48 EPA level (0.7 mg/L); thyroid review discusses higher exposures (~2.0 mg/L)
00:04:24 2025 IQ meta-analysis: higher levels (>1.5 mg/L) linked to small decrease; limits noted
00:05:09 “How much water?” Dose matters; bottled water as an option if concerned
00:05:36 Topical vs swallowed fluoride; toothpaste use in Jones’ family
00:06:11 What’s next: how removing fluoride affects dental health; providers decline due to politics
00:06:38 Host adds study context + new IQ study update; links mentioned
00:10:05 How to find your local water quality report + fluoride levels
00:11:07 Toothpaste backwash + kid toothpaste guidance; host’s personal note
00:12:22 Preview Part 2: higher-quality NC randomized study using toenail clippings